Dr. Omidian received his PhD in Chemical Engineering (Polymer Science) from Brunel University (London, UK) in 1998, and his MSc and BSc in Chemical Engineering from Tehran Polytechnic (Tehran, Iran) in 1990 and 1987, respectively. He served in academia and industry for over 27 years. He joined Purdue University in 2001, and pursued his postdoctoral fellowship in the Department of Industrial and Physical Pharmacy. From 2002 to 2007, he served as senior research scientist, research manager, and principal scientist at Kos Pharmaceuticals and then Abbott Laboratories where he conducted bench to Phase I clinical studies on novel drug delivery systems. After complete acquisition of Kos by Abbott in 2007, he joined Nova Southeastern University, and currently serving as professor and USP delegate at NSU’s college of pharmacy. He is the Associate Editor of the Journal of Bioactive and Compatible Polymers, and serving on the editorial board of over 15 other peer-reviewed journals. Dr. Omidian has over 175 peer-reviewed publications (cited by 2770, h-index of 23) and presentations, 25 book chapters and books, 3 US patents, over 20 US and world patent applications as well as 5 US provisional patent applications. He is also recipient of many research and teaching awards, including the Golden Apple in Teaching. His current research are hydrogels for pharmaceutical and biomedical applications, gastric retention drug delivery, and abuse-deterrent pharmaceutical dosage forms. Hamid Omidian,
Industrial and Physical Pharmacy; Phase I clinical studies on novel drug delivery systems; hydrogels for pharmaceutical and biomedical applications; gastric retention drug delivery, and abuse-deterrent pharmaceutical dosage forms.